LINETSKY DAVID (SVP, Life Sciences) sold 0.3% of their position (70.00 shares) of PHREESIA, INC. on the open market
Open‑market sale worth $682.50 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/27/2026ACC: 0001776729-26-000001
Officer· SVP, Life Sciences
Since Jul 2019
-70.00
Net shares
Net seller
$682.50
Total sold
2
Open market trades
0B · 2S
2
Total transactions
70.00 disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−35.00
Price / share
$9.15
Trade value
$320.25
% of position
0.2%
10/22/2026
22.27K→22.23K
Common Stock
Indirect
Shares
−35.00
Price / share
$10.35
Trade value
$362.25
% of position
0.2%
10/22/2026
22.23K→22.20K
Total
Net shares
−70.00
Net value
-$682.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/22/2026 | P · Purchase | −35.00 | $9.15 | $320.25 | 0.2% | 22.27K | 22.23K |
| Common Stock Indirect | 10/22/2026 | P · Purchase | −35.00 | $10.35 | $362.25 | 0.2% | 22.23K | 22.20K |
| Total | −70.00 | -$682.50 | ||||||
Derivative Transactions0
No derivative transactions reported